article thumbnail

Arcturus Therapeutics In Deal With Johnson & Johnson Innovation

socalTECH

San Diego-based RNA therapeutics developer Arcturus Therapeutics announced this morning that it is in a strategic collaboration deal, with Johnson & Johnson Innovation. Plus, Janssen will assume responsibility for development and commercialization costs associated with the new program.

Arcturus 100